Comparative effects of Bcl-2 over-expression and ZVAD.FMK treatment on dexamethasone and VP16-induced apoptosis in CEM cells

Cell Death and Differentiation

Volumn 5, Issue 5, 1998, Pages 432-439

  Benson, Roderick Simon Patrick ^a   Dive, Caroline ^a   Watson, Alastair John Mackenzie ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Apoptosis; Bcl 2; Caspase inhibitors; Caspases; Cell death; Necrosis

Indexed keywords

BENZYLOXYCARBONYLPHENYLALANYLALANYL FLUOROMETHYL KETONE; DEXAMETHASONE; ETOPOSIDE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL SIZE; CHROMATIN; CHROMATIN CONDENSATION; CONTROLLED STUDY; DEPOLARIZATION; HUMAN; HUMAN CELL; LYMPHOID CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOBLAST;

EID: 0031818946     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400366     Document Type: Article

References (26)

1. Arends MJ and Wyllie AH. (1991) Apoptosis: Mechanisms and roles in pathology. Int. Rev. Exp. Path. 32: 223-254
2. Benson RSP, Heer S, Dive C and Watson AJM. (1996) Characterisation of cell volume loss in CEM-C7A cells during dexamethasone-induced apoptosis. Am. J. Physiol 270: C1190-C1203
3. L can inhibit apoptosis in cells that have undergone FAS-induced protease activation. Proc. Natl. Acad. Sci. 94: 3759-3764
4. Brunet CL, Gunby RH, Benson RSP, Hickman JA, Watson AJM and Brady G. (1997) Commitment to clonogenic BCL-2-regulated cell death in a human lymphoid cell line is unaffected by caspase mactivation. Cell Death Differ. 5:107-115
5. Chen QC, Benson RSP, Whetton AD, Brant SR, Donowitz M, Montrose MH, Dive C and Watson AJM (1997) Role of acid/base homeostasis in the suppression of apoptosis in haemopoietic cells by v-Abl protein tyrosine kinase. J Cell Sci. 110: 379-387
6. Cohen GM. (1997) Caspases. the executioners of apoptosis. Biochemical Journal 326: 1-16
7. L antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 57: 62-67
8. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE and Wyllie AH (1992) Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry Biochim. Biophys Acta. 1133: 275-285
9. Fesus L, Thomázy V and Falus L. (1991) Induction and activation of tissue transliterations during programmed cell death. FEBS Lett 224. 104-108
10. Golstein P (1997) Controlling cell death. Science 275 1081-1082
11. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, Marzo I, Geuskens M and Kroemer G. (1997) The apoptosis-necrosis paradox, Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15. 1573-1581
12. Hoffmann EK and Simonsen LO. (1989) Membrane mechanisms in volume and pH regulation in vertebrate cells. Physiol. Rev. 69: 315-382
13. Kluck RM, Bossy-Wetzel E, Green, DR and Newmeyer D. (1997) The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science 275 1132-1136
14. Knight CRL, Ress RC and Griffin M. (1991) Apoptosis: a potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim. Biophys. Acta. 1096: 312-318
15. Kroemer G. (1997) The proto-oncogene Bcl-2 and it role in regulating apoptosis Nature Med 3 614-619
16. Leist M, Single B, Castoldi AF, Kühnle S and Nicotera P. (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185: 1481-1486
17. Lock RB and Stribinskiene L. (1996) Dual modes of death induced by etoposide in human epithelial tumor cells allow bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer. Res. 56: 4006-4012
18. McCarthy NJ, Whyte MK, Gilbert CS and Evan GI. (1997) Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell. Biol. 136: 215-227
19. Meisenholder GW, Martin SJ, Green DR, Nordberg J, Babior BM and Gottlieb RA. (1996) Events in apoptosis: acidification is downstream of protease activation and bcl-2 protection. J. Biol. Chem. 271: 16260-16262
20. Oltvai ZN and Korsmeyer SJ. (1994) Checkpoints of duelling dimers foil death wishes. Cell 79: 189-192
21. Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson, DW and Cohen GM (1996) Benzyloxycarbonyl-Val-Ala-Asp (Ome) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochemical Journal 315: 21-24
22. Wood AC, Waters CM, Garner A and Hickman JA. (1994) Changes in c-myc expression and the kinetics of dexamethasone-induced programmed cell death (apoptosis) in human lymphoid leukaemia cells Bnt J. Can. 69: 663-669
23. Xiang J, Chao DT and Korsmeyer SJ (1996) BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93: 14559-14563
24. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng Ti, Jones DP and Wang X. (1997) Prevention of apoptosis by Bcl-2 release of cytochrome c from mitochondria blocked. Science 275: 1129-1132
25. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX and Kroemer G (1995) Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181: 1661-1672
26. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gómez-Monterrey I, Castedo M and Kroemer G. (1996) Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183. 1533-1544.